SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/14/20 Cell MedX Corp. 10-Q 11/30/19 65:2.2M Empire Stock Transf… Inc |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 331K 2: EX-10.53 Loan Agreement and Note Payable Dated September 4, HTML 26K 2019 3: EX-10.54 Loan Agreement and Note Payable Dated September 6, HTML 26K 2019 4: EX-10.55 Loan Agreement and Note Payable Dated September HTML 26K 16, 2019 5: EX-10.56 Loan Agreement and Note Payable Dated September HTML 26K 19, 2019 6: EX-10.57 Loan Agreement and Note Payable Dated September HTML 26K 20, 2019 7: EX-10.58 Loan Agreement and Note Payable Dated October 30, HTML 26K 2019 8: EX-10.59 Loan Agreement and Note Payable Dated October 30, HTML 26K 2019, With Rain Communications Corp. 9: EX-31.1 Certification -- §302 - SOA'02 HTML 23K 10: EX-31.2 Certification -- §302 - SOA'02 HTML 23K 11: EX-32.1 Certification -- §906 - SOA'02 HTML 19K 12: EX-32.2 Certification -- §906 - SOA'02 HTML 19K 58: R1 Document and Entity Information HTML 68K 37: R2 Consolidated Balance Sheets HTML 79K 24: R3 Consolidated Balance Sheets - Parenthetical HTML 27K 46: R4 Consolidated Statements of Operations HTML 72K 57: R5 Consolidated Statement of Stockholders' Deficit HTML 57K 36: R6 Consolidated Statements of Cash Flows HTML 85K 23: R7 Organization and Nature of Operations HTML 28K 47: R8 Related Party Transactions Disclosure HTML 39K 53: R9 Inventory Disclosure HTML 24K 21: R10 Other Current Assets Disclosure HTML 22K 39: R11 Equipment Disclosure HTML 29K 54: R12 Unearned Revenue Disclosure HTML 32K 48: R13 Revenue Disclosure HTML 26K 22: R14 Notes and Advances Payable Disclosure HTML 49K 40: R15 Share Capital Disclosure HTML 53K 55: R16 Subsequent Event Disclosure HTML 22K 49: R17 Organization and Nature of Operations: Going HTML 24K Concern (Policies) 25: R18 Related Party Transactions Disclosure: Schedule of HTML 31K Amounts Due to Related Parties (Tables) 38: R19 Related Party Transactions Disclosure: Schedule of HTML 28K Transactions with Related Parties (Tables) 64: R20 Equipment Disclosure: Amortization schedule for HTML 29K the equipment (Tables) 43: R21 Unearned Revenue Disclosure: Changes to Unearned HTML 30K Revenue (Tables) 27: R22 Revenue Disclosure: Schedule of Revenue and HTML 25K Associated Costs (Tables) 32: R23 Notes and Advances Payable Disclosure: Schedule of HTML 41K Short-term Loans and Advances Outstanding (Tables) 65: R24 Share Capital Disclosure: Schedule of Stock Option HTML 31K Activity (Tables) 44: R25 Share Capital Disclosure: Schedule of Stock HTML 27K Options Outstanding (Tables) 28: R26 Share Capital Disclosure: Schedule of Warrant HTML 26K Activity (Tables) 33: R27 Share Capital Disclosure: Schedule of Warrant HTML 31K Details (Tables) 63: R28 Organization and Nature of Operations: Going HTML 23K Concern (Details) 45: R29 Related Party Transactions Disclosure: Schedule of HTML 33K Amounts Due to Related Parties (Details) 52: R30 Related Party Transactions Disclosure: Schedule of HTML 28K Transactions with Related Parties (Details) 60: R31 Inventory Disclosure (Details) HTML 36K 35: R32 Other Current Assets Disclosure (Details) HTML 25K 20: R33 Equipment Disclosure: Amortization schedule for HTML 30K the equipment (Details) 51: R34 Unearned Revenue Disclosure: Changes to Unearned HTML 31K Revenue (Details) 59: R35 Unearned Revenue Disclosure (Details) HTML 24K 34: R36 Revenue Disclosure: Schedule of Revenue and HTML 32K Associated Costs (Details) 19: R37 Notes and Advances Payable Disclosure: Schedule of HTML 41K Short-term Loans and Advances Outstanding (Details) 50: R38 Notes and Advances Payable Disclosure (Details) HTML 37K 61: R39 Share Capital Disclosure (Details) HTML 39K 42: R40 Share Capital Disclosure: Schedule of Stock Option HTML 28K Activity (Details) 62: R41 Share Capital Disclosure: Schedule of Stock HTML 30K Options Outstanding (Details) 31: R42 Share Capital Disclosure: Schedule of Warrant HTML 27K Activity (Details) 26: R43 Share Capital Disclosure: Schedule of Warrant HTML 32K Details (Details) 41: R44 Subsequent Event Disclosure (Details) HTML 22K 56: XML IDEA XML File -- Filing Summary XML 104K 30: EXCEL IDEA Workbook of Financial Reports XLSX 43K 13: EX-101.INS XBRL Instance -- cmxc-20191130 XML 571K 15: EX-101.CAL XBRL Calculations -- cmxc-20191130_cal XML 63K 16: EX-101.DEF XBRL Definitions -- cmxc-20191130_def XML 251K 17: EX-101.LAB XBRL Labels -- cmxc-20191130_lab XML 436K 18: EX-101.PRE XBRL Presentations -- cmxc-20191130_pre XML 395K 14: EX-101.SCH XBRL Schema -- cmxc-20191130 XSD 108K 29: ZIP XBRL Zipped Folder -- 0001393905-20-000009-xbrl Zip 53K
ex-10.59 |
LOAN AGREEMENT
Rain Communications Corp. (the “Lender”) with an address at 1130 West Pender Street, Unit 820, Vancouver, BC V6E 4A4, advanced USD$10,000 (the “Principal Sum”) to Cell MedX Corp. (the “Borrower”) of 123 W. Nye Ln, Suite 446, Carson City, NV 89706. The Lender advanced the funds on October 30, 2019.
The Borrower agrees to repay the Principal Sum on demand, together with interest calculated and compounded monthly at the rate of 6% per year (the “Interest”) calculated from October 30, 2019 (the “Effective Date”). The Borrower is liable for repayment of the Principal Sum, accrued Interest, and any additional costs that the Lender incurs in trying to collect the amount owed to him under the terms of this Loan Agreement.
The Borrower acknowledges that at any time, the Lender may, in its sole discretion, provide the Borrower with written instructions to convert any payment of Principal Sum, and/or Interest (together the “Convertible Amount”) into restricted units of common stock in the capital of the Borrower. The Convertible Amount will be converted into fully paid, non-assessable and, subject to the United States securities laws, restricted units of common stock in the capital of the Borrower on the terms and at a conversion price of the then current private placement offering.
The Borrower will evidence the debt and its repayment of the Principal Sum and the Interest with a promissory note in the attached for.
LENDER |
| BORROWER |
Rain Communications Corp. |
| Cell MedX Corp. |
|
|
|
Per: |
| Per: |
|
|
|
|
|
|
/s/ Raph Biggar |
| /s/ Yanika Silina |
Raph Biggar, President |
| Yanika Silina, CFO |
PROMISSORY NOTE
Principal Amount: USD$10,000 |
FOR VALUE RECEIVED Cell MedX Corp., (the “Borrower”) promises to pay on demand to the order of Rain Communications Corp. (the “Lender”) the sum of $10,000 lawful money of the United States of America (the “Principal Sum”) together with the Interest accrued on the Principal Sum calculated from October 30, 2019 (“Effective Date”) both before and after maturity, default and judgment at the Interest Rate as defined below.
For the purposes of this promissory note, Interest Rate means 6 per cent per year. Interest at the Interest Rate must be calculated and compounded monthly not in advance from and including the Effective Date (for an effective rate of 6.2% per annum calculated monthly), and is payable together with the Principal Sum when the Principal Sum is repaid.
The Borrower may repay the Principal Sum, and the Interest in whole or in part at any time.
Any time prior to this Promissory Note being repaid the Lender may, in its sole discretion, provide the Borrower with written instructions to convert any payment of Principal Sum, and/or Interest into restricted units of common stock in the capital of the Borrower. Payments will be converted into fully paid, non-assessable and, subject to United States securities laws, restricted units of common stock in the capital of the Borrower (the “Conversion Units”) on the terms and at a conversion price of the then current private placement offering.
The Borrower waives presentment, protest, notice of protest and notice of dishonor of this promissory note.
BORROWER
Cell MedX Corp.
Per:
/s/ Yanika Silina
Yanika Silina, CFO
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 1/14/20 | None on these Dates | ||
For Period end: | 11/30/19 | |||
10/30/19 | ||||
List all Filings |